期刊文献+

自噬在膜性肾病补体攻膜复合物所致足细胞损伤中的作用 被引量:4

Effect of autophagy on podocyte injury induced by complement membrane attack complex in membranous nephropathy
下载PDF
导出
摘要 目的探讨自噬在补体攻膜复合物C5b-9所致足细胞损伤中的作用。方法利用酵母多糖活化正常人血清制作攻膜复合物C5b-9;分别用含C5b-9的酵母多糖活化血清(ZAS)、雷帕霉素、氯喹处理MCP-5足细胞,透射电子显微镜观察自噬泡形成,蛋白印迹、免疫荧光检测LC3、F-actin、podocin、nephrin表达。结果在ZAS刺激下,足细胞内LC3Ⅱ表达明显增加,自噬泡生成增多,骨架结构严重破坏。氯喹处理足细胞加重骨架结构破坏、下调F-actin、podocin和nephrin表达,而雷帕霉素减轻上述损伤(P<0.01或0.05)。结论自噬可保护足细胞抵抗亚溶解型C5b-9所致损伤。 Objective To explore the role of autophagy in podocyte injury induced by complement membrane attack complex C5b-9.Methods C5b-9 was prepared by coculture of normal human serum and yeast polysaccharide.MPC-5 podocytes were treated with zymosan activation serum(ZAS)containing C5b-9,rapamycin or chloroquine.The autophagosomes were observed by transmission electron microscopy,while LC3,F-actin,podocin and nephrin expression was detected by Western blot and immunofluorescence.Results ZAS treatment upregulated LC3 II expression and autophagosome formation,and destroyed skeletal structure in podocytes.Co-treatment with chloroquine aggravated the cytoskeleton damage and downregulated expression of F-actin,podocin and nephrin,while rapamycin alleviated ZAS-induced injuries in podocytes(P<0.01 or 0.05).Conclusion Autophagy can protect podocytes from sublytic C5b-9 induced injury.
作者 吴洪銮 安宁 钟珍 李志航 刘伟敬 刘华锋 杨陈 WU Hong-luan;AN Ning;ZHONG Zhen;LI Zhi-hang;LIU Wei-jing;LIU Hua-feng;YANG Chen(Institute of Nephrology,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524001,China)
出处 《广东医科大学学报》 2020年第5期526-531,共6页 Journal of Guangdong Medical University
基金 国家自然科学基金(No.81700627) 广东省自然科学基金(No.2018A030313231) 湛江市科技计划项目(No.2018A01040)。
关键词 膜性肾病 足细胞 补体攻膜复合物 自噬 membranous nephropathy podocyte complement membrane attack complex autophagy
  • 相关文献

参考文献3

二级参考文献34

  • 1曹雪莹,汤力,魏日胞.特发性膜性肾病244例临床与病理分析[J].实用医学杂志,2007,23(21):3386-3388. 被引量:9
  • 2Haas M, Meehan SM, Karrison TG, eta[. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and1995-1997[J]. AmJ Kidney Dis, 1997,30(5) : 621-631.
  • 3Zuo K, Wu Y, Li SJ, etal. Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population[J]. Clin Nephrol,2013,79(6) :445-453.
  • 4Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, et al. Inducible rodent models of acquired podocyte diseases[J]. Am J Physiol Renal Physiol, 2009,296 ( 2 ) : F213-F229.
  • 5Ronco P, Debiec H. Target antigens and nephritogenic antibodies in membranous nephropathy of rats and men [J]. Semin Immunopathol, 2007,29 : 445- 458.
  • 6Debiee H, Guigonis V, Mougenot B, et al. Antenatalmembranous glomerulonephritis due to anti-neutral endopeptidase antibodies[J]. N Engl J Med, 2002, 346 (26): 2053-2060.
  • 7Debiec H, Nauta J, Coulet F, et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies[J]. Lancet, 2004, 364(4): 1252- 1259.
  • 8Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase Az receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009,361 ( 1 ) : 11- 21.
  • 9Hofstra JM, Beck LH Jr, Beck DM et al. Anti-phospholipase Az receptor antibodies correlate with clinical status in idiopathic membranous nephropathy[J]. Clin J Am Soc Nephroi, 2011,6 (6) :1286-1291.
  • 10Hoxha E, Harendza S, Zahner G, et al. An immunofluorescence test for phospholipase-Az receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis[J]. Nephrol Dial Transplant, 2011,26(8) :2526-2532.

共引文献16

同被引文献75

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部